Sports Eligibility Risk : Athletes face eligibility concerns because WADA prohibits unapproved substances, and BPC-157 is commonly discussed within that restricted category
Animal studies report effects on tendon, ligament, and gastrointestinal tissue repair, but no Phase 3 human trials have been completed
Individuals managing chronic gut issues like IBS, IBD, or leaky gut Those seeking ongoing wellness maintenance rather than immediate results Anyone looking for general inflammation control and systemic support Individuals who prefer a slow-release option to support daily function and recovery By targeting the intestines more directly, Delayed BPC-157 is particularly helpful for those with digestive sensitivity or those using the peptide for internal inflammation rather than muscular or skeletal pain
Documented practice is to remove the vial, draw the dose, and return it to refrigeration rather than leaving it on the counter during prep
No evidence: Comparative effectiveness between different peptides or combinations